Form 4 for COGT Cogent Biosciences, Inc.
Accepted 2026-05-21 16:30:06 ET · period of report 2026-05-19 · accession 0001193125-26-234578 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-21 16:30 | 2026-05-19 | COGT | Robbins Andrew R | Pres, CEO, Dir | G - Gift | $0.00 | -160.0K | 497.5K | -24% | $0 | |
| I | 2026-05-21 16:30 | 2026-05-19 | COGT | Robbins Andrew R | Pres, CEO, Dir | G - Gift | $0.00 | +160.0K | 160.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-05-19 | G | D | 160,000 | $0.00 | 497,503 | D | — | — | (F1) On May 19, 2026, Mr. Robbins transferred 160,000 shares of common stock to a family trust for estate planning purposes. |
| 2 | Common | Common Stock | 2026-05-19 | G | A | 160,000 | $0.00 | 160,000 | I By trust | — | — | (F1) On May 19, 2026, Mr. Robbins transferred 160,000 shares of common stock to a family trust for estate planning purposes. |